These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Low-dose digoxin in patients with heart failure. Less toxic and at least as effective? van Veldhuisen DJ J Am Coll Cardiol; 2002 Mar; 39(6):954-6. PubMed ID: 11897435 [No Abstract] [Full Text] [Related]
5. Digoxin and reduction in mortality in systolic and diastolic heart failure at low serum digoxin concentrations. Rahimtoola SH Eur Heart J; 2006 Jul; 27(13):1630; author reply 1630-1. PubMed ID: 16760215 [No Abstract] [Full Text] [Related]
6. Digoxin for the treatment of heart failure. Hallberg P; Michaëlsson K; Melhus H N Engl J Med; 2003 Feb; 348(7):661-3; author reply 661-3. PubMed ID: 12587575 [No Abstract] [Full Text] [Related]
7. Optimal digoxin concentrations for patients with heart failure. Carbonin P; Zuccalà G JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771104 [No Abstract] [Full Text] [Related]
8. Digoxin in heart failure. Spencer AP Crit Care Nurs Clin North Am; 2003 Dec; 15(4):447-52. PubMed ID: 14717389 [TBL] [Abstract][Full Text] [Related]
9. Digoxin--new perspective on an old drug. Eichhorn EJ; Gheorghiade M N Engl J Med; 2002 Oct; 347(18):1394-5. PubMed ID: 12409540 [No Abstract] [Full Text] [Related]
10. Optimal digoxin concentrations for patients with heart failure. de Denus S; Spinler SA JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771103 [No Abstract] [Full Text] [Related]
11. Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure. Souza FC; Baptista TM; Marques EB; Barros RB; Scaramello CB Int J Cardiol; 2015 Jan; 179():343-4. PubMed ID: 25464482 [No Abstract] [Full Text] [Related]
12. Therapeutic digoxin level in chylous drainage with no detectable plasma digoxin level. Taylor MD; Kim SS; Vaias LJ Chest; 1998 Nov; 114(5):1482-4. PubMed ID: 9824036 [TBL] [Abstract][Full Text] [Related]
13. The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease. Sharma R; Guy M; Rudenski A; Lamerton E; Kalra PA QJM; 2009 Oct; 102(10):747-50. PubMed ID: 19602599 [No Abstract] [Full Text] [Related]
14. Adherence to the medical regime in patients with heart failure. Muzzarelli S; Brunner-La Rocca H; Pfister O; Foglia P; Moschovitis G; Mombelli G; Stricker H Eur J Heart Fail; 2010 Apr; 12(4):389-96. PubMed ID: 20172940 [TBL] [Abstract][Full Text] [Related]
15. [Digoxin in elderly patients: therapeutic drug monitoring to increase the efficiency of therapy (a review)]. Pushkin AS; Yakovlev AA; Zadvor'ev SF; Rukavishnikova SA; Akhmedov TA Adv Gerontol; 2016; 29(2):297-305. PubMed ID: 28514549 [TBL] [Abstract][Full Text] [Related]
16. Digoxin therapeutic drug monitoring: an audit and review. Sidwell A; Barclay M; Begg E; Moore G N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536 [TBL] [Abstract][Full Text] [Related]
17. The practice of digoxin therapeutic drug monitoring. Barclay M; Begg E N Z Med J; 2003 Dec; 116(1187):U704. PubMed ID: 14752532 [No Abstract] [Full Text] [Related]
18. [Digoxin in reduced heart failure and sinus rhythm. When should it be indicated in 2018?]. Formiga F; Ariza A Rev Esp Geriatr Gerontol; 2018; 53(3):119-120. PubMed ID: 29598972 [No Abstract] [Full Text] [Related]
19. Comparison of target concentration intervention strategy with conventional dosing of digoxin. Rajendran SD; Rao YM; Thanikachalam S; Muralidharan TR; Anbalagan M Indian Heart J; 2005; 57(3):265-7. PubMed ID: 16196188 [TBL] [Abstract][Full Text] [Related]
20. Digoxin for patients with heart failure in sinus rhythm. McMurray J; Davie AP Lancet; 1997 Aug; 350(9076):519. PubMed ID: 9274604 [No Abstract] [Full Text] [Related] [Next] [New Search]